|
1
|
DeSantis C, Siegel R, Bandi P and Jemal A:
Breast cancer statistics, 2011. CA Cancer J Clin. 61:409–418. 2011.
View Article : Google Scholar
|
|
2
|
Kwong DL, Sham JS, Leung LH, Cheng AC, Ng
WM, Kwong PW, Lui WM, Yau CC, Wu PM, Wei W and Au G: Preliminary
results of radiation dose escalation for locally advanced
nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 64:374–381.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng AQ, Song XR, Yu JM, Wei L and Wang
XW: Liposome transfected to plasmid-encoding endostatin gene
combined with radiotherapy inhibits liver cancer growth in nude
mice. World J Gastroenterol. 11:4439–4442. 2005.PubMed/NCBI
|
|
4
|
Harari PM and Huang SM: Head and neck
cancer as a clinical model for molecular targeting of therapy:
combining EGFR blockade with radiation. Int J Radiat Oncol Biol
Phys. 49:427–433. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu LL, Smith MJ, Sun BS, Wang GJ, Redmond
HP and Wang JH: Combined IFN-gamma-endostatin gene therapy and
radiotherapy attenuates primary breast tumor growth and lung
metastases via enhanced CTL and NK cell activation and attenuated
tumor angiogenesis in a murine model. Ann Surg Oncol. 16:1403–1411.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang W and Li XY: Anti-tumor effect of
pEgr-interferon-γ-endostatin gene-radiotherapy in mice bearing
Lewis lung carcinoma and its mechanism. Chin Med J (Engl).
118:296–301. 2005.PubMed/NCBI
|
|
7
|
Li Y, Guo C, Wang Z, Gong P, Sun Z and
Gong S: Enhanced effects of TRAIL-endostatin-based
double-gene-radiotherapy on suppressing growth, promoting apoptosis
and inducing cell cycle arrest in vascular endothelial cells. J
Huazhong Univ Sci Technolog Med Sci. 32:167–172. 2012. View Article : Google Scholar
|
|
8
|
Wu C, Li X and Tian M: Effect of
pEgr-TNFalpha gene radiotherapy on mice melanoma. Melanoma Res.
15:185–190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Y, Yu XH, Zha X and Kong W:
Adenovirus-mediated HSV-TK gene therapy using hTERT promoter in CNE
cells in vitro. Chem Res Chinese Universities. 25:60–63. 2009.
|
|
10
|
Wang WD, Chen ZT, Li DZ, Duan YZ, Wang ZX
and Cao ZH: HSV-TK gene therapy of lung adenocarcinoma xenografts
using a hypoxia/radiation dual-sensitive promoter. Ai Zheng.
23:788–793. 2004.(In Chinese).
|
|
11
|
Mizutani Y, Nakanishi H, Yamamoto K, Li
YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B and
Miki T: Downregulation of Smac/DIABLO expression in renal cell
carcinoma and its prognostic significance. J Clin Oncol.
23:448–454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pluta P, Cebula-Obrzut B, Ehemann V, Pluta
A, Wierzbowska A, Piekarski J, Bilski A, Nejc D, Kordek R, Robak T,
Smolewski P and Jeziorski A: Correlation of Smac/DIABLO protein
expression with the clinico-pathological features of breast cancer
patients. Neoplasma. 58:430–435. 2011. View Article : Google Scholar
|
|
13
|
Fulda S, Wick W, Weller M and Debatin KM:
Smac agonists sensitize for Apo2L/TRAIL or anticancer drug-induced
apoptosis and induce regression of malignant glioma in vivo. Nat
Med. 8:808–815. 2002.PubMed/NCBI
|
|
14
|
Lok CN and Ponka P: Identification of a
hypoxia response element in the transferin receptor gene. J Biol
Chem. 274:24147–24152. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okino ST, Chichester CH and Whitlock JP
Jr: Hypoxia-inducible mammalian gene expression analyzed in vivo at
a TATA-driven promoter and at an initiator-driven promoter. J Biol
Chem. 273:23837–23843. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kwon OJ, Kim PH, Huyn S, Wu L, Kim M and
Yun CO: A hypoxia- and α-fetoprotein-dependent oncolytic adenovirus
exhibits specific killing of hepatocellular carcinomas. Clin Cancer
Res. 16:6071–6082. 2010.
|
|
17
|
Barnes MN, Coolidge CJ, Hemminki A,
Alvarez RD and Curiel DT: Conditionally replicative adenoviruses
for ovarian cancer therapy. Mol Cancer Ther. 1:435–439.
2002.PubMed/NCBI
|
|
18
|
Wu JH, Wang HF, Wang ZC, Xu K, Qi YL, Li
JH, Gong SL and Liu Y and Liu Y: Conditionally replicating
adenovirus combined with gene-targeted radiotherapy induces
apoptosis via TRAIL death receptors in MDA-MB-231 cells. Mol Med
Rep. 8:299–305. 2013.PubMed/NCBI
|
|
19
|
Dai M, Cui P, Yu M, Han J, Li H and Xiu R:
Melatonin modulates the expression of VEGF and HIF-1 alpha induced
by CoCl2 in cultured cancer cells. J Pineal Res.
44:121–126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu G, Gong P, Zhao H, Wang Z, Gong S and
Cai L: Effect of low-level radiation on the death of male germ
cells. Radiat Res. 165:379–389. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang SW, Chanda D, Coody JJ, Rivera AA,
Waehler R, Siegal GP, Douglas JT and Ponnazhagan S: Conditionally
replicating adenovirus expressing TIMP2 in creases survival in a
mouse model of disseminated ovarian cancer. PLoS One. 6:e251312011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng FQ, Xu Y, Yang RJ, Wu B, Tan XH, Qin
YD and Zhang QW: Combination effect of oncolytic adenovirus therapy
and herpes simplex virus thymidine kinase/ganciclovir in hepatic
carcinoma animal models. Acta Pharmacol Sin. 30:617–627. 2009.
View Article : Google Scholar
|
|
23
|
Senzer N, Mani S, Rosemurgy A, Nemunaitis
J, Cunningham C, Guha C, Bayol N, Gillen M, Chu K, Rasmussen C,
Rasmussen H, Kufe D, Weichselbaum R and Hanna N: TNFerade biologic,
an adenovector with a radiation-inducible promoter, carrying the
human tumor necrosis factor alpha gene: a phase I study in patients
with solid tumors. J Clin Oncol. 22:592–601. 2004. View Article : Google Scholar
|
|
24
|
Kasuya H, Takeda S, Nomoto S and Nakao A:
The potential of oncolytic virus therapy for pancreatic cancer.
Cancer Gene Ther. 12:725–736. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Teyssier F, Bay JO, Dionet C and Verrelle
P: Cell cycle regulation after exposure to ionizing radiation. Bull
Cancer. 86:345–357. 1999.(In French).
|
|
26
|
Deplanque G, Céraline J, Mah-Becherel MC,
Cazenave JP, Bergerat JP and Klein-Soyer C: Caffeine and the G2/M
block override: a concept resulting from a misleading cell kinetic
delay, independent of functional p53. Int J Cancer. 94:363–369.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo C, Li Y, Zhang H, Wang Z, Jin M, Zhang
L, An L, Hu G, Liu X, Liu Y, Du H and Sun Z: Enhancement of
antiproliferative and proapoptotic effects of cadmium chloride
combined with hSmac in hepatocellular carcinoma cells.
Chemotherapy. 57:27–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
